OGT and liver cancer: O‐GlcNAc expression was measured after 24 h of etoposide treatment, and the effect of O‐GlcNAc transferase (OGT) inhibition by OSMI‐1 on etoposide's anticancer activity in HepG2 human liver cancer cells was quantitatively analyzed.